Some 330 jobs hit as Novartis closes Morphosys, WiWo reports
BERLIN (Reuters) – Swiss pharmaceutical group Novartis is winding up the German biotech company Morphosys, which it acquired at the beginning of the year, German news outlet WirtschaftsWoche reported on Thursday, saying 330 jobs would be affected.
“In November 2024, we made the decision to close the Morphosys sites in Germany and the U.S. by the end of 2025 and to integrate all portfolio activities into Novartis,” WiWo cited Novartis as saying.
Novartis did not immediately respond to an emailed request for comment from Reuters.
($1 = 0.9610 euros)
(Writing by Friederike Heine; Editing by Madeline Chambers)
Related
Novartis Cuts MorphoSys Sites in Boston, Munich, Affecting 330 Jobs
Novartis is closing down sites in Germany and Boston that were picked up in its $2.9 billion acquisition of MorphySys, Reut
Congress Clears Bill Designed to Widen Pool of Candidates for…
Agencies could use subject matter experts to develop position-specific technical assessments that could include structured interviews. Imag
Remote jobs paying $100,000 or more are making a comeback,…
The market for high-paying remote jobs is heating up. Ladders, a career site for six-figure positions, reports 10.4% of roles that pay $250,000 or more were ad
Factbox-European companies cut jobs as economy sputters By Reuters
(Reuters) -Difficult economic conditions and persistently weak demand for many products have forced companies across Europe to freeze hiring or cut jobs. Here
